Literature DB >> 7034783

AMP deaminase isozymes in human tissues.

N Ogasawara, H Goto, Y Yamada, T Watanabe, T Asano.   

Abstract

In human, there are four AMP deaminase (AMP aminohydrolase, EC 3.5.4.6) isozymes: E1, E2, M and L. Chromatographic, electrophoretic and immunological studies showed the existence of isozymes E1 and E2 in erythrocytes, isozyme M in muscle and isozyme L in liver and brain. The tissues such as heart, kidney and spleen contained isozymes E1, E2 and L. Isozymes E1, M and L were isolated as apparently homogeneous preparations. The three isozymes were all tetramers composed of identical subunits, but differing slightly in molecular weight; isozyme E1 showed a subunit molecular weight of 80,000, isozyme M 72,000 and isozyme L 68,000. They were immunologically different from one another. The antisera precipitated only the corresponding enzyme and did not precipitate any other isozyme. The three isozymes were also different in kinetic and regulatory properties. Isozyme E2 was very similar to isozyme E1 in immunological an kinetic properties, although isozyme E2 could be separated from isozyme E1 by phosphocellulose chromatography, and zonal electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7034783     DOI: 10.1016/0304-4165(82)90337-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  32 in total

1.  Molecular characterization of adenosine 5'-monophosphate deaminase--the key enzyme responsible for the umami taste of nori (Porphyra yezoensis Ueda, Rhodophyta).

Authors:  Seiko Minami; Minoru Sato; Yoshihiro Shiraiwa; Koji Iwamoto
Journal:  Mar Biotechnol (NY)       Date:  2011-04-26       Impact factor: 3.619

2.  AMP-deaminase from human term placenta.

Authors:  A Swieca; I Rybakowska; G Nagel-Starczynowska; E Kossowska; K Kaletha
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

3.  Coronary autoregulation and purine release in normoxic heart at various cytoplasmic phosphorylation potentials: disparate effects of adenosine.

Authors:  Y H Kang; R T Mallet; R Bünger
Journal:  Pflugers Arch       Date:  1992-06       Impact factor: 3.657

4.  Isolation and regulation of piglet cardiac AMP deaminase.

Authors:  A M Hohl; C M Hohl
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

5.  Full-size form of human liver AMP-deaminase?

Authors:  M Szydlowska; Z Chodorowski; I Rybakowska; G Nagel-Starczynowska; K Kaletha
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

6.  Human liver AMP-deaminase--oligomeric forms of the enzyme.

Authors:  M Szydłowska; G Nagel-Starczynowska; I Rybakowska; A Swieca; K Kaletha
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

7.  Expression of three stage-specific transcripts of AMP deaminase during myogenesis.

Authors:  R L Sabina; N Ogasawara; E W Holmes
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

8.  Developmental forms of human skeletal-muscle AMP deaminase. The kinetic and regulatory properties of the enzyme.

Authors:  K Kaletha; G Nowak
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

Review 9.  Molecular biology of AMP deaminase deficiency.

Authors:  M Gross
Journal:  Pharm World Sci       Date:  1994-04-15

10.  Developmental changes of chicken liver AMP deaminase.

Authors:  J Spychała; K Kaletha; W Makarewicz
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.